PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) › Cash & EquivalentsPACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $78.46M2009: $89.23M2010: $147.65M2011: $58.87M2012: $46.54M2013: $26.36M2014: $36.45M2015: $33.63M2016: $16.77M2017: $16.51M2018: $18.84M2019: $29.63M2020: $81.61M2021: $460.73M2022: $325.09M2023: $179.91M2024: $55.37M2025: $63.71M$63.71M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$63.71M+15.1%2024$55.37M-69.2%2023$179.91M-44.7%2022$325.09M-29.4%2021$460.73M+464.5%2020$81.61M+175.5%2019$29.63M+57.2%2018$18.84M+14.2%2017$16.51M-1.5%2016$16.77M-50.1%2015$33.63M-7.7%2014$36.45M+38.3%2013$26.36M-43.4%2012$46.54M-20.9%2011$58.87M-60.1%2010$147.65M+65.5%2009$89.23M+13.7%2008$78.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share